BuybackJun 29, 2026, 04:23 PM
Novo Nordisk Repurchases DKK 2.1B Shares Under Current Program
AI Summary
Novo Nordisk provided an update on its share repurchase program. Under the program initiated on May 6, 2026, the company has repurchased 7,250,000 B shares totaling DKK 2,098,848,921 as of June 26, 2026. This is part of a larger DKK 15 billion program launched on February 4, 2026, under which DKK 5,898,848,910 worth of shares have been repurchased to date. The company now holds 39,194,480 B shares as treasury shares, representing 0.9% of its share capital.
Key Highlights
- Novo Nordisk repurchased 7,250,000 B shares for DKK 2,098,848,921 under the program initiated May 6, 2026.
- The current repurchase program aims to buy back up to DKK 11,200,000,010.45 in B shares by February 1, 2027.
- Since the last announcement on June 22, 2026, 1,050,000 B shares were repurchased for DKK 321,843,743.
- Overall, since February 4, 2026, DKK 5,898,848,910 worth of B shares have been repurchased.
- The total share repurchase program is for up to DKK 15 billion over 12 months starting February 4, 2026.
- Novo Nordisk currently holds 39,194,480 B shares as treasury shares, representing 0.9% of its share capital.
Price Impact
More from NVO